Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I

Journal of Investigative Medicine

Volumn 45, Issue 9, 1997, Pages 584-591

  Donohue, Thomas J ^a   Dworkin, Lance D ^a   Ma, Junxian ^a   Lango, Miriam N ^a   Catanese, Veronica M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium channel blockers; Hypertension; Insulin like growth factors; Peripheral vasodilators; Ventricular hypertrophy

Indexed keywords

ANIMALIA;

ANTIHYPERTENSIVE AGENT; ENALAPRIL; HYDRALAZINE; MESSENGER RNA; NIFEDIPINE; SOMATOMEDIN C;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD PRESSURE; DRUG EFFECT; HEART; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HYPERTENSION; MALE; METABOLISM; ORGAN SIZE; PATHOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ENALAPRIL; HEART; HYDRALAZINE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN-LIKE GROWTH FACTOR I; MALE; MYOCARDIUM; NIFEDIPINE; ORGAN SIZE; RATS; RATS, INBRED SHR; RNA, MESSENGER;

EID: 0031306627     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Casale PN, Devereux R, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986;105:173-8.
2. Kannel WB. Epidemiological aspects of heart failure. In: Weber KT, editor. Congestive Heart Failure. Philadelphia: WB Saunders Co; 1989:1-9.
3. Izumo S, Nadal-Ginard B, Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 1988;85:339-43.
4. Schwartz K, de la Bastie D, Bouveret P, Oliviero P, Alonso S, Buckingham M. Skeletal muscle actin mRNAs accumulate in hypertrophied adult rat hearts. Circ Res 1986; 59:551-5.
5. Izumo S, Lompre AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B, Mahdavi V. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. J Clin Invest 1987;79:970-7.
6. Komuro I, Kurabayashi M, Takaku F, Yazaki Y. Expression of cellular oncogenes in the myocardium during developmental stage and pressure overload hypertrophy of the rat heart. Circ Res 1988;62:1075-9.
7. Donohue TJ, Dworkin LD, Lango MN, Fliegner K, Lango RP, Benstein JA, Slater WR, Catanese VM. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation 1994;89:799-809.
8. Engelmann GL, Boehm KD, Haskell JF, Khairallah PA, Ilan J. Insulin-like growth factors and neonatal cardiomyocyte development: ventricular gene expression and membrane receptor variations in normotensive and hypertensive rats. Mol Cell Endocrinol 1989;63:1-14.
9. Sen S, Tarazi RC, Bumpus FM. Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res 1977;11:427-33.
10. Jesperson LT, Nyborg NCB, Pederson OL, Mikkelsen EO, Mulvany MJ. Cardiac mass and peripheral vascular structure in hydralazine-treated spontaneously hypertensive rats. Hypertension 1985;7:734-41.
11. Tsoporis J, Leenen FHH. Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. Hypertension 1988;11:376-86.
12. Dunn FG, Oigman W, Ventura HO, Messerli FH, Kobrin I, Frohlich ED. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol 1984;53:105-8.
13. Nakashima Y, Fouad FM, Tarazi RC. Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 1984;53:1044-9.
14. Amodeo C, Kobrin I, Ventura HO, Messerli FH, Frohlich ED. Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension. Circulation 1986;73:108-13.
15. Dunn FG, Ventura HO, Messerli FH, Kobrin I, Frohlich ED. Time course of regression of left ventricular hypertrophy in hypertensive patients treatedwith atenolol. Circulation 1987;76:254-8.
16. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Cardiovascular effects of verapamil in patients with essential hypertension. Circulation 1987;75:1030-6.
17. Pfeffer JM, Pfeffer MA, Frohlich ED. Validity of an indirect tailcuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 1971;78:957-62.
18. Meltzer SJ, Mane SM, Wood PK, Johnson L, Needleman SW. An improvement of the single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Biotechniques 1987;8:148-9.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
20. Murphy LJ, Bell GI, Duckworth ML, Friesen HG. Identification, characterization, and regulation of a complementary deoxyribonucleic acid which encodes insulin-like growth factor-I. Endocrinology 1987;121:243-8.
21. Lowe WL Jr, Roberts CT Jr, Lasky SR, LeRoith D. Differential expression of alternative 5′-untranslated regions in mRNAs encoding rat insulin-like growth factor-I. Proc Natl Acad Sci USA 1987;84:8946-50.
22. Fort P, Marty L, Piechaczyk M, El Sabrouty S, Dani C, Jeanteur P, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family. Nuc Acids Res1985;13:1431-42.
23. Feinberg AP, Vogelsteiri B. A technique for radiolabelling DNA restriction fragments to high specific activity. Anal Biochem 1983;132:6-13.
24. Macara IG. Oncogenes and cellular signal transduction. Physiol Rev 1989;69:797-820.
25. Wickstrom EL, Bacon TA, Gonzalez A, Freeman DL, Lyman GH, Wickstrom E. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci USA 1988;85:1028-32.
26. 1. Nature 1987;328:445-9.
27. Biro S, Fu Y, Yu Z, Epstein SE. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Proc Natl Acad Sci USA 1993;90:654-8.
28. Arai H, Nakao K, Saito Y, Morii N, Sugawara A, Yamada T, Itoh H, Shiono S, Mukoyama M, Ohkubo H, Nakanishi S, Imura H. Augmented expression of atrial natriuretic polypeptide gene in ventricles of SHR and SHR-stroke prone rats. Circ Res 1988;62:926-30.
29. Lee RT, Bloch KD, Pfeffer JM, Pfeffer MA. Neer EJ, Seidman CE. ANF gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J Clin Invest 1988;81:431-4.
30. Eppenberger-Eberhardt M, Flamme I, Kurer V, Eppenberger HM. Reexpression of alpha-smooth muscle actin isoform in cultured adult rat cardiomyocytes. Devel Biol 1990;139:269-78.
31. Eid H, Larson DM, Springhorn JP, Attawia MA, Nayak RC. Smith TW, Kelly RA. Role of epicardial mesothelial cells in the modification of phenotype and function of adult rat ventricular myocytes in primary coculture. Circ Res 1992;71:40-50.
32. Claycomb WC. ANF mRNA is developmentally regulated in heart ventricles and actively expressed in cultured ventricular cardiac muscle cells of rat and human. Biochem J 1988;255:617-20.
33. Eppenberger-Eberhardt M. Messerli M. Eppenberger HM, Reinecke M. New occurrence of ANF and storage in secretorially active granules in adult rat ventricular cardiomyocytes in long-term culture. J Mol Cell Cardiol 1993;25:753-7.
34. Nag AC, Cheng M. Biochemical evidence for cellular dedifferentiation in adult rat cardiac muscle cells in culture: expression of myosin isozymes. Biochem Biophys Res Commun 1986;137:855-62.
35. Eppenberger ME, Hauser I, Baechi T, Schaub MC, Brunner UT, Dechesne CA, Eppenberger HM. Immunocytochemical analysis of the regeneration of myofibrils in long-term cultures of adult cardiomycytes of the rat. Dev Biol 1988;130:1-15.
36. Ueno H, Perryman MB, Roberts R, Schneider MD. Differentiation of cardiac myocytes after mitogen withdrawal exhibits three sequential states of the ventricular growth response. J Cell Biol 1988;107:1911-8.
37. Parker TG, Packer SE, Schneider MD. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest 1990; 85:507-14.
38. Bugaisky LB, Zak R. Differentiation of adult rat cardiac myocytes in cell culture. Circ Res 1989;64:493-500.
39. Villareal FJ, Dillman WH. Cardiac hypertrophy-induced changes in messenger RNA levels for TGF-betal, fibronectin and collagen. Am J Physiol 1992;262:H1861-6.
40. Kardami E, Fandrich RR. Heparin-binding mitogen(s) in the heart: in search of origin and function. In: Kedes L, Stockdale F, eds. Cellular and molecular biology of muscle development New York: Liss; 1989:315-25.
41. Ito H, Hiroe M, Hirata Y, Tsujino M, Schichiri M. IGF-I induces cardiac hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes. Circulation 1993;87:1715-21.
42. Donath MY, Zapf J, Eppenberger-Eberhardt M, Froesch ER, Eppenberger HM. IGF-I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc Natl Acad Sci USA 1994;91:1686-90.
43. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr. Insulin-like growth factor-I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 1995;95:619-27.
44. Dzau VJ. Cardiac renin-angiotensin system: molecular and functional aspects. Am J Med 1988;84 (suppl 3A):22-7.
45. Baker KM, Chemin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 1990;259:H324-32.
46. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988;62:749-56.
47. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989; 13:305-14.
48. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75:977-84.
49. Baker KM, Chemin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 1990;259:H324-32.
50. Brink M, Delafontaine P. Angiotensin II stimulates insulin-like growth factor I gene expression in rat heart. Circulation 1995;92:I62-3.
51. Delafontaine P, Lou H. Angiotensin II regulates IGF-I gene expression in vascular smooth muscle cells. J Biol Chem 1993;268:16866-70.
52. Rabinowitz B, Parmley WW, Har-Zahav Y, Elazar E, Blumlein S, Nerinsky R, Neufeld HN. Correlation between effects of hydralazine on force and on the adenyl cyclase system of ventricular myocardium in dogs and cats. Cardiovasc Res 1986;20:215-20.
53. Tsoporis J, Fields N, Lee RMKW, Leenen FHH. Arterial vasodilation and cardiovascular structural changes in normotensive rats. Am J Physiol 1991;260:H1944-H52.
54. Limas C, Westrum B, Limas CJ. Comparative effects of hydralazine and captopril on the cardiovascular changes in spontaneously hypertensive rats. Am J Pathol1984;117:360-71.
55. Leenen FHH, Smith DL, Farkas RM, Reeves RA, Marquez-Julio A. Vasodilators and regression of cardiac hypertrophy: hydralazine versus prazosin in hypertensive humans. Am J Med 1987;82:969-78.
56. Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982;51:787-801.
57. Sadoshima J, Izumo S. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Circ Res 1993;73:424-38.
58. Henrich CJ, Simpson PC. Differential acute and chronic response of protein kinase C in cultured neonatal rat heart myocytes to alpha-1-adrenergic and phorbol ester stimulation. J Mol Cell Cardiol 1988;20:1981-5.